What if you could streamline and accelerate your early phase development while maximizing flexibility, time and cost, so you can get the data you need faster?
Dr Rebecca Coutts
Rebecca discusses the development of an oncology product utilizing XcelodoseTM microdosing technology.
Brendan Dempsey
Brendan talks about how Speed to Study is used to help streamline early phase development in clinical trials.
Brendan Dempsey
Brendan shares a Speed to StudyTM case study of oral solid dose capsule filling for early liver disease treatment.
Katty Roggensack
Katty shares an example of how Speed to StudyTM helped expedite IMP study materials, to analize their impact on seasonal allergies.
FACTS
Early phase safety & efficacy data is key to determining the next steps of the drug development journey
Conducting early phase clinical trials in Australia offers both key financial incentives and can significantly accelerate timelines
Unnecessary waste is a huge cost to the pharma industry
Filling API directly into capsules eliminates standard formulation and analytical requirements, delivering cost and time efficiencies
FEATURES
The PCI WayTM - swiftly initiating early phase trials to establish proof of concept, efficacy, and stability of your drug candidates quickly and efficiently
“Accelerate your drug to proof of concept with PCI’s Speed to StudyTM services.”
Mark Shepanski
Executive Director, Operations
"Companies that take steps to identify potential problems in advance and then proactively stop the development of an imperiled trial have a much higher likelihood of ultimately reaching the market with their drugs.”
BENEFITS
